{
    "Trade/Device Name(s)": [
        "ARCHITECT HE4 Assay",
        "ARCHITECT HE4 Calibrators",
        "ARCHITECT HE4 Controls"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K093957",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072939"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OIU",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "December 22, 2009",
    "Summary Letter Received Date": "December 23, 2009",
    "Submission Date": "December 21, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.6010",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Tumor Associated Antigen Immunological Test System",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "cancer molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "HE4"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescent assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for the ARCHITECT HE4 assay, calibrators, and controls for quantitative determination of HE4 antigen in human serum to monitor recurrence or progression of epithelial ovarian cancer.",
    "Indications for Use Summary": "Quantitative determination of HE4 antigen in human serum as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer, used in conjunction with other clinical methods.",
    "fda_folder": "Immunology"
}